Renal protection strategies in the perioperative period

Best Practice and Research: Clinical Anaesthesiology

Volumn 18, Issue 4, 2004, Pages 645-660

  Jarnberg, Per Olof ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Acetylcysteine; Acute pathophysiology drug therapy; ANP; Apoptosis; Calcium channel blockers; Contrast media; Dopamine; Fenoldopam; Fluid therapy; Furosemide; Growth factors; Human; Ischaemic preconditioning; Kidney failure; Mannitol; Randomized controlled trials; Risk factors

Indexed keywords

ACETYLCYSTEINE; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANARITIDE; ATRIAL NATRIURETIC FACTOR; CALCIUM; CALCIUM ANTAGONIST; CEPHALOSPORIN DERIVATIVE; CISPLATIN; CONTRAST MEDIUM; CYCLOSPORIN; DILTIAZEM; DOPAMINE; DOPAMINE 1 RECEPTOR; EPIDERMAL GROWTH FACTOR; FENOLDOPAM MESILATE; FUROSEMIDE; HEMOGLOBIN; MANNITOL; MYOGLOBIN; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOGENIC PROTEIN 1; SCATTER FACTOR; SOMATOMEDIN C; TACROLIMUS; THEOPHYLLINE; UNINDEXED DRUG;

ACUTE KIDNEY FAILURE; CLINICAL TRIAL; DIALYSIS; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG MEGADOSE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERNATREMIA; HYPOTENSION; HYPOVOLEMIA; KIDNEY FUNCTION; KIDNEY TUBULE NECROSIS; LOW DRUG DOSE; OLIGURIA; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TACHYCARDIA; VASOCONSTRICTION; VASODILATATION;

EID: 4344669743     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2004.05.009     Document Type: Article

References (100)

1. Nolan C. Anderson R. Hospital-aquired acute renal failure Journal of the American Society of Nephrology 9 1998 710-718
2. Thadhani R. Pascual M. Bonventre J.V. Acute renal failure New England Journal of Medicine 334 1996 1448-1460
3. Anderson R.J. O'B'Brien M. MaWhinney S. et al. Mild renal failure is associated with adverse outcome after cardiac valve surgery American Journal of Kidney Diseases 35 2000 1127-1134
4. Chertow G.M. Lazarus J.M. Christiansen C.L. et al. Preoperative renal risk stratification Circulation 95 1997 878-884
5. Chertow G.M. Christiansen C.L. Cleary P.D. et al. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis Archives of Internal Medicine 155 1995 1505-1511
6. Pruchnicki M.C. Dasta J.F. Acute renal failure in hospitalized patients: part I Annals of Pharmacotherapy 36 2002 1261-1267
7. Star R.A. Treatment of acute renal failure Kidney International 54 1998 1817-1831
8. Metnitz P.G. Krenn C.G. Steltzer H. et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients Critical Care Medicine 30 2002 2051-2058
9. Mehta R.L. Chertow G.M. Acute renal failure definitions and classification: time for change? Journal of the American Society of Nephrology 14 2003 2178-2187
10. Sugrue M. Jones F. Deane S.A. et al. Intra-abdominal hypertension is an independent cause of postoperative renal impairment Archives of Surgery 134 1999 1082-1085
11. Blantz R.C. Pathophysiology of pre-renal azotemia Kidney International 53 1998 512-523
12. Brezis M. Rosen S. Hypoxia of the renal medulla: its implications for disease New England Journal of Medicine 332 1995 647-655
13. Jaffe R. Ariel I. Beeri R. Frequent apoptosis in human kidneys after acute renal hypoperfusion Experimental Nephrology 5 1997 399-403
14. Kerr J.F. Wyllie A.H. Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics British Journal of Cancer 26 1972 239-257
15. Koch T. Origin and mediators involved in sepsis and the systemic inflammatory response syndrome Kidney International 64 supplement 1998 S66-S69
16. Lieberthal W. Levine J.S. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury American Journal of Physiology 271 1996 F477-F488
17. Hirschberg R. Ding H. Growth factors and acute renal failure Seminars in Nephrology 18 1998 191-207
18. Safirstein R. DiMari J. Megyesi J. Price P. Mechanisms of renal repair and survival following acute injury Seminars in Nephrology 18 1998 519-522
19. Price P.M. Megyesi J. Safirstein R.L. Cell cycle regulation: repair and regeneration in acute renal failure Seminars in Nephrology 23 2003 449-459
20. Bergin E. Levine J.S. Koh J.S. Lieberthal W. Mouse proximal tubular cell-cell adhesion inhibits apoptosis by a cadherin-dependent mechanism American Journal of Physiology: Renal Physiology 278 2000 F758-F768
21. Kanellis J. Fraser S. Katerelos M. Power D.A. Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells American Journal of Physiology: Renal Physiology 278 2000 F905-F915
22. Yo Y. Morishita R. Nakamura S. et al. Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells Kidney International 54 1998 1128-1138
23. Ueda N. Kaushal G.P. Shah S.V. Apoptotic mechanisms in acute renal failure American Journal of Medicine 108 2000 403-415
24. Heyman S.N. Reichman J. Brezis M. Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia Investigative Radiology 34 1999 685-691
25. Prins J.M. Buller H.R. Kuijper E.J. et al. Once versus thrice daily gentamicin in patients with serious infections Lancet 341 1993 335-339
26. Anderson R.J. O'Brien M. MaWhinney S. et al. Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery. VA Cooperative Study #5 Kidney International 55 1999 1057-1062
27. Mangano C.M. Diamondstone L.S. Ramsay J.G. et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group Annals of Internal Medicine 128 1998 194-203
28. Suwa T. Hogg J.C. Klut M.E. et al. Interleukin-6 changes deformability of neutrophils and induces their sequestration in the lung American Journal of Respiratory and Critical Care Medicine 163 2001 970-976
29. Kribben A. Edelstein C.L. Schrier R.W. Pathophysiology of acute renal failure Journal of Nephrology 12 supplement 2 1999 S142-S151
30. Solomon R. Werner C. Mann D. et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents New England Journal of Medicine 331 1994 1416-1420
31. Levy E.M. Viscoli C.M. Horwitz R.I. The effect of acute renal failure on mortality: a cohort analysis JAMA 275 1996 1489-1494
32. Liano F. Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study: Madrid Acute Renal Failure Study Group Kidney International 50 1996 811-818
33. Obialo C.I. Crowell A.K. Okonofua E.C. Acute renal failure mortality in hospitalized African Americans: age and gender considerations Journal of the National Medical Association 94 2002 127-134
34. Perrone R.D. Madias N.E. Levey A.S. Serum creatinine as an index of renal function: new insights into old concepts Clinical Chemistry 38 1992 1933-1953
35. Molitoris B.A. Transitioning to therapy in ischemic acute renal failure Journal of the American Society of Nephrology 14 2003 265-267
36. Lieberthal W. Nigam S.K. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable American Journal of Physiology: Renal Physiology 278 2000 F1-F12
37. Conger J.D. Interventions in clinical acute renal failure: what are the data? American Journal of Kidney Diseases 26 1995 565-576
38. Rosen S. Heyman S.N. Difficulties in understanding human acute tubular necrosis: limited data and flawed animal models Kidney International 60 2001 1220-1224
39. Novis B.K. Roizen M.F. Aronson S. Thisted R.A. Association of preoperative risk factors with postoperative acute renal failure Anesthesia and Analgesia 78 1994 143-149
40. Noirhomme P. Buche M. Louagie Y. et al. Ischemic complications of abdominal aortic surgery Journal of Cardiovascular Surgery 32 1991 451-455
41. DuBose T.D.Jr Warnock D.G. Mehta R.L. et al. Acute renal failure in the 21st century: recommendations for management and outcomes assessment American Journal of Kidney Diseases 29 1997 793-799
42. Davidman M. Olson P. Kohen J. et al. Iatrogenic renal disease Archives of Internal Medicine 151 1991 1809-1812
43. Thurau K. Boylan J.W. Acute renal success. The unexpected logic of oliguria in acute renal failure American Journal of Medicine 61 1976 308-315
44. Alpert R.A. Roizen M.F. Hamilton W.K. et al. Intraoperative urinary output does not predict postoperative renal function in patients undergoing abdominal aortic revascularization Surgery 95 1984 707-711
45. Better O.S. Rubinstein I. Winaver J.M. Knochel J.P. Mannitol therapy revisited (1940-1997) Kidney International 52 1997 886-894
46. Magovern Jr. G.J. Bolling S.F. Casale A.S. et al. The mechanism of mannitol in reducing ischemic injury: hyperosmolarity or hydroxyl scavenger? Circulation 70 1984 I91-I95
47. Barry K.G. Cohen A. Knochel J.P. et al. Mannitol infusion. II. The prevention of acute functional renal failure during resection of an aneurysm of the abdominal aorta New England Journal of Medicine 264 1961 967-971
48. Poullis M. Mannitol and cardiac surgery Thoracic and Cardiovascular Surgeon 47 1999 58-62
49. van Valenberg P.L. Hoitsma A.J. Tiggeler R.G. et al. Mannitol as an indispensable constituent of an intraoperative hydration protocol for the prevention of acute renal failure after renal cadaveric transplantation Transplantation 44 1987 784-788
50. Dishart M.K. Kellum J.A. An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure Drugs 59 2000 79-91
51. Dorman H.R. Sondheimer J.H. Cadnapaphornchai P. Mannitol-induced acute renal failure Medicine; Analytical Reviews of General Medicine, Neurology, Psychiatry, Dermatology, and Pediatrics 69 1990 153-159
52. Shilliday I.R. Quinn K.J. Allison M.E. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study Nephrology, Dialysis, Transplantation 12 1997 2592-2596
53. Lassnigg A. Donner E. Grubhofer G. et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery Journal of the American Society of Nephrology 11 2000 97-104
54. Brown C.B. Ogg C.S. Cameron J.S. High dose frusemide in acute renal failure: a controlled trial Clinical Nephrology 15 1981 90-96
55. +-ATPase activity in rat renal cortical tubule cells American Journal of Physiology 255 1988 F666-F673
56. Weldon B.C. Monk T.G. The patient at risk for acute renal failure. Recognition, prevention, and preoperative optimization Anesthesiology Clinics of North America 18 2000 705-717
57. Chertow G.M. Sayegh M.H. Allgren R.L. Lazarus J.M. Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group American Journal of Medicine 101 1996 49-53
58. Bellomo R. Chapman M. Finfer S. et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group Lancet 356 2000 2139-2143
59. Kellum J.A. Use of dopamine in acute renal failure: a meta-analysis Critical Care Medicine 29 2001 1526-1531
60. Carey R.M. Siragy H.M. Ragsdale N.V. et al. Dopamine-1 and dopamine-2 mechanisms in the control of renal function American Journal of Hypertension 3 1990 59S-63S
61. Murphy M.B. McCoy C.E. Weber R.R. et al. Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopam Circulation 76 1987 1312-1318
62. Mathur V.S. Swan S.K. Lambrecht L.J. et al. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects Critical Care Medicine 27 1999 1832-1837
63. Kien N.D. Moore P.G. Jaffe R.S. Cardiovascular function during induced hypotension by fenoldopam or sodium nitroprusside in anesthetized dogs Anesthesia and Analgesia 74 1992 72-78
64. Tumlin J.A. Wang A. Murray P.T. Mathur V.S. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy American Heart Journal 143 2002 894-903
65. Kini A.S. Mitre C.A. Kamran M. et al. Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam American Journal of Cardiology 89 2002 999-1002
66. Halpenny M. Lakshmi S. O'Donnell A. et al. Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting Anaesthesia 56 2001 953-960
67. Halpenny M. Rushe C. Breen P. et al. The effects of fenoldopam on renal function in patients undergoing elective aortic surgery European Journal of Anaesthesiology 19 2002 32-39
68. Vesely D.L. Natriuretic peptides and acute renal failure American Journal of Physiology: Renal Physiology 285 2003 F167-F177
69. Allgren R.L. Marbury T.C. Rahman S.N. et al. Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group New England Journal of Medicine 336 1997 828-834
70. Lewis J. Salem M.M. Chertow G.M. et al. Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group American Journal of Kidney Diseases 36 2000 767-774
71. Kurnik B.R. Allgren R.L. Genter F.C. et al. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy American Journal of Kidney Diseases 31 1998 674-680
72. Meyer M. Pfarr E. Schirmer G. et al. Therapeutic use of the natriuretic peptide ularitide in acute renal failure Renal Failure 21 1999 85-100
73. Clark L.C. Farghaly H. Saba S.R. Vesely D.L. Amelioration with vessel dilator of acute tubular necrosis and renal failure established for 2 days American Journal of Physiology. Heart and Circulation Physiology 278 2000 H1555-H1564
74. + transport in rabbit inner medullary collecting duct cells. Role of prostaglandin E2 Journal of Clinical Investigation 89 1992 1411-1417
75. Agmon Y. Brezis M. Acute renal failure: a multifactorial syndrome. Pathogenesis and prevention strategies Contributions to Nephrology 102 1993 23-36
76. Rodicio J.L. Campo C. Ruilope L.M. Renal effects of calcium antagonists Nephrology, Dialysis, Transplantation 10 supplement 9 1995 17-22
77. Leonetti G. Rappelli A. Are there differences in the renal effects of calcium antagonists? Journal of Hypertension 11 Supplement 1993 S45-S48
78. Wagner K. Albrecht S. Neumayer H.H. Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem: a prospective randomized study American Journal of Nephrology 7 1987 287-291
79. Morales J.M. Andres A. Rodriguez Paternina E. et al. Calcium antagonist therapy prevents chronic cyclosporine nephrotoxicity after renal transplantation: a prospective study Transplantation Proceedings 24 1992 89-91
80. Antonucci F. Calo L. Rizzolo M. et al. Nifedipine can preserve renal function in patients undergoing aortic surgery with infrarenal crossclamping Nephron 74 1996 668-673
81. Young E.W. Diab A. Kirsh M.M. Intravenous diltiazem and acute renal failure after cardiac operations Annals of Thoracic Surgery 65 1998 1316-1319
82. Lake E.W. Humes H.D. Acute renal failure: directed therapy to enhance renal tubular regeneration Seminars in Nephrology 14 1994 83-97
83. Liu Y. Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms American Journal of Physiology 277 1999 F624-F633
84. Megyesi J. Andrade L. Vieira Jr. J.M. et al. Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure Kidney International 60 2001 2164-2172
85. Hirschberg R. Kopple J. Lipsett P. et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure Kidney International 55 1999 2423-2432
86. Liu K.D. Molecular mechanisms of recovery from acute renal failure Critical Care Medicine 31 2003 S572-S581
87. Bonventre J.V. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure Journal of the American Society of Nephrology 14 supplement 1 2003 S55-S61
88. Tepel M. van der Giet M. Schwarzfeld C. et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine New England Journal of Medicine 343 2000 180-184
89. Birck R. Krzossok S. Markowetz F. et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis Lancet 362 2003 598-603
90. Bush H.L.Jr Huse J.B. Johnson W.C. et al. Prevention of renal insufficiency after abdominal aortic aneurysm resection by optimal volume loading Archives of Surgery 116 1981 1517-1524
91. Hesdorffer C.S. Milne J.F. Meyers A.M. et al. The value of Swan-Ganz catheterization and volume loading in preventing renal failure in patients undergoing abdominal aneurysmectomy Clinical Nephrology 28 1987 272-276
92. Better O.S. Stein J.H. Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis New England Journal of Medicine 322 1990 825-829
93. Murry C.E. Jennings R.B. Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124-1136
94. Hawaleshka A. Jacobsohn E. Ischaemic preconditioning: mechanisms and potential clinical applications Canadian Journal of Anaesthesiology 45 1998 670-682
95. Bonventre J.V. Kidney ischemic preconditioning Current Opinion in Nephrology and Hypertension 11 2002 43-48
96. Cohen M.V. Baines C.P. Downey J.M. Ischemic preconditioning: from adenosine receptor of KATP channel Annual Review of Physiology 62 2000 79-109
97. Warltier D.C. al-Wathiqui M.H. Kampine J.P. Schmeling W.T. Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane Anesthesiology 69 1988 552-565
98. de Klaver M.J. Manning L. Palmer L.A. Rich G.F. Isoflurane pretreatment inhibits cytokine-induced cell death in cultured rat smooth muscle cells and human endothelial cells Anesthesiology 97 2002 24-32
99. Julier K. da Silva R. Garcia C. et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study Anesthesiology 98 2003 1315-1327
100. Dworkin L.D. Serum cystatin C as a marker of glomerular filtration rate Current Opinion in Nephrology and Hypertension 10 2001 551-553